Rowena Delos Santos

Medicine & Life Sciences

1. Transplants 100%
2. Kidney 92%
3. Transplant Recipients 80%
4. Kidney Transplantation 52%
5. Tacrolimus 35%
6. Allografts 33%
7. Autoantigens 31%
8. Pancreas Transplantation 23%
9. Chronic Renal Insufficiency 22%
10. Transplantation 21%
11. HLA Antigens 21%
12. Antibodies 21%
13. eculizumab 21%
14. Immunoglobulin Class Switching 19%
15. Pancreas 19%
16. Hydroxymethylglutaryl CoA Reductases 19%
17. Thrombotic Microangiopathies 18%
18. Chimeric Antigen Receptors 18%
19. Chronic Kidney Failure 17%
20. Acute Kidney Injury 16%
21. Hyperparathyroidism 16%
22. Lymphoproliferative Disorders 16%
23. Immunoglobulin Isotypes 16%
24. Manuscripts 16%
25. Cytomegalovirus 15%
26. Bone Diseases 15%
27. Rituximab 15%
28. Retrospective Studies 14%
29. Dialysis 14%
30. Glomerulonephritis 14%
31. Graft vs Host Disease 14%
32. Vimentin 14%
33. Cardiomyopathies 13%
34. Interleukin-17 13%
35. Interleukin-10 13%
36. Population 13%
37. Cell- and Tissue-Based Therapy 13%
38. Coronary Disease 12%
39. Renal Dialysis 12%
40. Therapeutics 12%
41. Immunosuppressive Agents 11%
42. Cohort Studies 10%
43. Body Composition 10%
44. T-Lymphocytes 9%
45. Obesity 9%
46. Collagen 9%
47. Safety 9%
48. Viremia 8%
49. Renal Replacement Therapy 8%
50. Organ Transplantation 8%